Synonyms |
Neplanocin A;72877-50-0;Neplanocin-A;(1s,2r,5r)-5-(6-amino-9h-purin-9-yl)-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol;(-)-Neplanocin A;A-11079-B1B;(1S,2R,5R)-5-(6-aminopurin-9-yl)-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol;CHEMBL8771;NPC-A;4-Cyclopentene-1,2-diol, 3-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)-, (1S,2R,3R)-;NEOPLANOCIN A;NSC 316458;-neplanocin A;(-)-9-(trans-2,trans-3-Dihydroxy-4-(hydroxymethyl)-cyclopent-4-enyl)-adenine;SCHEMBL10469277;DTXSID30993658;CHEBI:227034;BDBM50006222;CCG-208688;HY-130430;CS-0107829;Q27456496;5-(6-Amino-purin-9-yl)-3-hydroxymethyl-cyclopent-3-ene-1,2-diol;5-(6-Amino-9H-purin-9-yl)-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol;5-(6-Amino-purin-9-yl)-3-hydroxymethyl-cyclopent-3-ene-1,2-diol(NP-A);5-(6-Amino-purin-9-yl)-3-hydroxymethyl-cyclopent-3-ene-1,2-diol(NPA);(1S,2R,5R)-5-(6-Amino-purin-9-yl)-3-hydroxymethyl-cyclopent-3-ene-1,2-diol;(neplanocinA)5-(6-Amino-purin-9-yl)-3-hydroxymethyl-cyclopent-3-ene-1,2-diol;5-(6-Amino-purin-9-yl)-3-hydroxymethyl-cyclopent-3-ene-1,2-diol (Neplanocin A);5-(6-Amino-purin-9-yl)-3-hydroxymethyl-cyclopent-3-ene-1,2-diol (Neplonocin A);5-(6-Amino-purin-9-yl)-3-hydroxymethyl-cyclopent-3-ene-1,2-diol(neplanocin A); |
IUPAC Name |
(1S,2R,5R)-5-(6-aminopurin-9-yl)-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol |
Molecular Weight |
397.3 |
Molecular Formula |
C20H24N2O2.2ClH |
Canonical SMILES |
COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)O.Cl.Cl |
InChI |
InChI=1S/C11H13N5O3/c12-10-7-11(14-3-13-10)16(4-15-7)6-1-5(2-17)8(18)9(6)19/h1,3-4,6,8-9,17-19H,2H2,(H2,12,13,14)/t6-,8-,9+/m1/s1 |
InChIKey |
XUGWUUDOWNZAGW-VDAHYXPESA-N |
Boiling Point |
632.6±65.0°C at 760 mmHg |
Melting Point |
220-227°C |
Purity |
≥98% |
Density |
1.9±0.1 g/cm3 |
Solubility |
Soluble in DMF, DMSO |
Appearance |
Colorless Acicular Crystal |
Application |
Antibiotics, Antineoplastic |
Storage |
Please store the product under the recommended conditions in the Certificate of Analysis. |